A frontier AI company developing AI-designed medicines and therapeutics.
Its EDEN models support therapeutic discovery across multiple modalities and disease areas, including in vivo cell therapy.
Leadership & Board
Currently, no data available
Latest Estimated Valuation
Estimated Valuation―
Estimated Valuation―
Total Amount Raised$140M
Total Amount Raised$140M
Total Funding Rounds1
Total Funding Rounds1
Latest Funding Amount$140M
Latest Funding Amount$140M
Latest Funding RoundSeries C
Latest Funding RoundSeries C
Post-Money Valuation―
Post-Money Valuation―
Main Enterprise Clients
A snapshot of major enterprise customers that use this private company’s products or services, highlighting its commercial reach and market adoption.